Wiley Bros. Aintree Capital, LLC Pfizer Inc Transaction History
Wiley Bros. Aintree Capital, LLC
- $5.07 Billion
- Q3 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 362,153 shares of PFE stock, worth $9.26 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
362,153
Previous 175,395
106.48%
Holding current value
$9.26 Million
Previous $4.91 Million
113.57%
% of portfolio
0.21%
Previous 0.22%
Shares
15 transactions
Others Institutions Holding PFE
# of Institutions
3,259Shares Held
3.62BCall Options Held
77.2MPut Options Held
122M-
Vanguard Group Inc Valley Forge, PA516MShares$13.2 Billion0.27% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.9 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.43 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA164MShares$4.19 Billion0.85% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA130MShares$3.33 Billion0.73% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $144B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...